FDA Guards Gardasil’s Market Share

So far in the states, Gardasil has been the only FDA approved vaccine for the double-whammy strain of HPV that causes cervical cancer. However, in Europe Cervarix has been kicking HPV’s butt and protecting women across the continent. While the drug has been in the FDA review process for foreva-eva, it looks like new data submitted by the makers, GlaxoSmithKline, will stall approvals now until 2009. Sheesh! What’s a girl gotta do to get some options? [Wall Street Journal]

Posted Under: , , , ,
  • Zergnet: Simply Irresistible

  • HowAboutWe

  • afc-right-ad

  • Popular
  • afc-right-ad-2

  • We’re Loving